Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Eli Lilly and Company (LLY) had Revenue of $22.97B for the most recently reported fiscal quarter, ending 2026-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$22.97B
Net Income	$7.09B
Cost of Goods Sold	$3.27B
Gross Profit	$19.71B
Operating Expenses	$14.00B
Operating Income	$8.98B
Non-Operating Income/Expense	$269.00M
Pre-Tax Income	$9.25B
Normalized Pre-Tax Income	$9.25B
Income after Taxes	$7.09B
Income from Continuous Operations	$7.09B
Consolidated Net Income/Loss	$7.09B
Normalized Income after Taxes	$7.09B
EBIT	$8.98B
EBITDA	$9.51B
Weighted-Average Shares Outstanding (Basic)	892.40M
Weighted-Average Shares Outstanding (Diluted)	893.70M
Earnings per Share (EPS) (Basic)	$7.95
Earnings per Share (EPS) (Diluted)	$7.94
Balance Sheet Financials
Current Assets	$64.67B
Property, Plant, and Equipment	$29.29B
Long-Term Assets	$77.61B
Total Assets	$142.28B
Current Liabilities	$47.74B
Long-Term Debt	$47.86B
Long-Term Liabilities	$60.66B
Total Liabilities	$108.40B
Common Equity	$33.88B
Tangible Shareholders Equity	$6.92B
Shareholders Equity	$33.88B
Common Shares Outstanding	947.20M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$16.02B
Cash Flow from Investing Activities	$-19.31B
Cash Flow from Financial Activities	$4.96B
Beginning Cash	$7.27B
End Cash	$8.95B
Increase/Decrease in Cash	$1.68B
Stock-Based Compensation	$362.00M
Common Stock Dividends Paid	$-3.09B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.35
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.59
Debt to Equity Ratio	1.62
Gross Margin	85.78%
Operating Margin	39.08%
EBIT Margin	39.08%
EBITDA Margin	--
Pre-Tax Profit Margin	40.25%
Profit Margin	30.88%
Free Cash Flow	$10.76B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.16
Inventory Turnover	0.19
Receiveable Turnover	0.98
Days Sales in Receivables	91.96
Return on Equity	20.94%
Return on Tangible Equity	102.53%
Return on Assets	4.99%
Return on Investments	8.68%
Book Value Per Share	$35.77
Free Cash Flow per Share	$12.04
Operating Cash Flow per Share	$17.93

Data from Zacks Investment Research, Inc.